PUMA BIOTECHNOLOGY, INC. Intellectual Property Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exclusive License Agreement, dated September 16, 2022, by and between the Company and Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company...
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2022
Amendment No. 3 to the License Agreement, dated February 24, 2021, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2021
Amendment No. 2 to License Agreement dated October 29, 2020, between the Company and Pfizer Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2021
Second Amendment to the License Agreement, dated November 25, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
First Amendment to the License Agreement, dated September 17, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
Amendment to the License Agreement, dated December 18, 2019, by and between the Company and Knight Therapeutics, Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
License Agreement, dated March 29, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2019
License Agreement, dated January 9, 2019, by and between the Company and Knight Therapeutics Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2019
Amendment No. 1, dated April 20, 2018, to the License Agreement by and between the Company and Specialised Therapeutics Asia Pte Ltd
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2018
License Agreement, dated March 30, 2018, between the Company and Pint Pharma International SA
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2018
License Agreement, dated November 20, 2017, by and between the Company and Specialised Therapeutics Asia Pte Ltd
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2018
Amendment No. 1 to License Agreement between Puma Biotechnology, Inc. and Pfizer Inc.
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2014
LICENSE AGREEMENT
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
LICENSE AGREEMENT
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011